Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma.

Parasitol Int

Department of Parasitology, Graduate School of Medicine, Gunma University, Gunma, Japan; Department of Parasitology, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address:

Published: June 2020

Intestinal helminths induce immune suppressive responses thought to regulate inflammatory diseases including allergies and autoimmune diseases. This study was designed to evaluate whether helminthic infections suppress the natural development of systemic lupus erythematosus (SLE) in NZBWF1 mice. Infection of NZBWF1 SLE-prone mice with two nematodes failed to establish long-lasting settlement. However, the Hymenolepis microstoma (Hm) rodent tapeworm successfully established long-term parasitization of NZBWF1 mice and was used to evaluate the suppressive effects of helminth infection. Ten-month-old NZBWF1 mice developed symptoms including autoantibody generation, proteinuria, glomerular histopathology, and splenomegaly, but mice infected with Hm at 2 months of age did not show any clinical signs. Furthermore, infection with Hm reduced lymphocyte activation and increased regulatory T cells in the spleen and mesenteric lymph nodes. These results indicate that infection with Hm protects NZBWF1 mice from naturally developing SLE and suggest that pathological immunity is attenuated, presumably because of the induction of regulatory T cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parint.2020.102057DOI Listing

Publication Analysis

Top Keywords

nzbwf1 mice
20
systemic lupus
8
lupus erythematosus
8
mice infected
8
hymenolepis microstoma
8
regulatory cells
8
mice
7
nzbwf1
6
suppression systemic
4
erythematosus nzbwf1
4

Similar Publications

Klotho deficiency is prevalent in various chronic kidney diseases. Although klotho is known to bind transforming growth factor β (TGFβ) receptor 1 to antagonize renal fibrosis, TGFβ also maintains regulatory T cells with inducing forkhead box protein P3 (FOXP3). Female New Zealand Black/White F (NZBWF1) mice were divided into two groups (n = 10 for each): one group was treated with daily subcutaneous injection of klotho protein (30 μg/kg/day) for 8 weeks, and the other only received vehicle.

View Article and Find Full Text PDF

Objective: Acute intranasal (IN) instillation of lupus-prone NZBWF1 mice with crystalline silica (cSiO) triggers robust lung inflammation that drives autoimmunity. Prior studies in other preclinical models show that soluble epoxide hydrolase (sEH) inhibition upregulates pro-resolving lipid metabolites that are protective against pulmonary inflammation. Herein, we assessed in NZBWF1 mice how acute IN cSiO exposure with or without the selective sEH inhibitor TPPU influences lipidomic, transcriptomic, proteomic, and histopathological biomarkers of inflammation, fibrosis, and autoimmunity.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of a JAK1-selective inhibitor (ABT-317) on systemic lupus erythematosus (SLE) in mice, exploring both preventive and therapeutic benefits.
  • Treatment with ABT-317 shows promising results, as it improves kidney and saliva functions, reduces inflammation, and leads to significant health improvements in treated mice.
  • The findings suggest that JAK1 inhibition could translate into effective treatments for human lupus nephritis, with potential long-lasting effects even after stopping the drug.
View Article and Find Full Text PDF

Tertiary lymphoid structures (TLSs) are formed in tissues targeted by chronic inflammation processes, such as infection and autoimmunity. In Sjögren's disease, the organization of immune cells into TLS is an important part of disease progression. Here, we investigated the dynamics of tissue resident macrophages in the induction and expansion of salivary gland TLS.

View Article and Find Full Text PDF

Background: Inorganic polyphosphates (polyPs) are linear chains of phosphates that accelerate blood clotting. Targeting polyP has been shown to reduce thrombosis.

Objectives: To identify and characterize anti-polyP monoclonal antibodies that could be used as analytical tools and as antithrombotic agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!